Class information for:
Level 1: PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
7893 1239 44.9 92%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
157 21931 BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PCA3 Author keyword 129 85% 5% 68
2 TMPRSS2 ERG Author keyword 76 86% 3% 38
3 PROSTATE CANCER ANTIGEN 3 Author keyword 73 96% 2% 23
4 PROSTATE CANCER GENE 3 Author keyword 31 92% 1% 12
5 TMPRSS2 Author keyword 28 64% 2% 27
6 PROSTATE CANCER ANTIGEN 3 HUMAN Author keyword 27 92% 1% 11
7 TMPRSS2ERG Author keyword 24 82% 1% 14
8 TMPRSS2 ERG FUSION Author keyword 23 86% 1% 12
9 ERG Author keyword 19 18% 8% 94
10 ERG REARRANGEMENT Author keyword 17 100% 1% 8

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 PCA3 129 85% 5% 68 Search PCA3 Search PCA3
2 TMPRSS2 ERG 76 86% 3% 38 Search TMPRSS2+ERG Search TMPRSS2+ERG
3 PROSTATE CANCER ANTIGEN 3 73 96% 2% 23 Search PROSTATE+CANCER+ANTIGEN+3 Search PROSTATE+CANCER+ANTIGEN+3
4 PROSTATE CANCER GENE 3 31 92% 1% 12 Search PROSTATE+CANCER+GENE+3 Search PROSTATE+CANCER+GENE+3
5 TMPRSS2 28 64% 2% 27 Search TMPRSS2 Search TMPRSS2
6 PROSTATE CANCER ANTIGEN 3 HUMAN 27 92% 1% 11 Search PROSTATE+CANCER+ANTIGEN+3++HUMAN Search PROSTATE+CANCER+ANTIGEN+3++HUMAN
7 TMPRSS2ERG 24 82% 1% 14 Search TMPRSS2ERG Search TMPRSS2ERG
8 TMPRSS2 ERG FUSION 23 86% 1% 12 Search TMPRSS2+ERG+FUSION Search TMPRSS2+ERG+FUSION
9 ERG 19 18% 8% 94 Search ERG Search ERG
10 ERG REARRANGEMENT 17 100% 1% 8 Search ERG+REARRANGEMENT Search ERG+REARRANGEMENT

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 TMPRSS2 ERG FUSION 104 82% 5% 60
2 TMPRSS2 ERG GENE FUSION 95 78% 5% 63
3 DD3PCA3 79 88% 3% 37
4 MOLECULAR URINE ASSAY 68 70% 5% 57
5 TMPRSS2 ERG 66 83% 3% 38
6 DNA BASED DETECTION 64 82% 3% 37
7 PCA3 57 70% 4% 48
8 DD3 48 91% 2% 20
9 PSA RECURRENCE 38 76% 2% 26
10 TMPRSS2 ERG FUSION TRANSCRIPTS 36 65% 3% 34

Journals

Reviews



Title Publ. year Cit. Active
references
% act. ref.
to same field
Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer 2015 3 68 46%
The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications 2015 2 42 62%
Common Gene Rearrangements in Prostate Cancer 2011 93 75 69%
Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion 2012 40 46 83%
The Mutational Landscape of Prostate Cancer 2013 35 66 59%
The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature 2014 4 80 99%
ETS gene fusions in prostate cancer 2009 115 76 64%
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice 2009 107 79 67%
Recurrent gene fusions in prostate cancer 2008 298 95 41%
Clinical use of novel urine and blood based prostate cancer biomarkers: A review 2014 9 73 56%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MICHIGAN TRANSLAT PATHOL 17 27% 4.3% 53
2 SECT TRANSLAT PROSTATE CANC 15 50% 1.7% 21
3 MARTINI CLIN PROSTATE CANC 6 36% 1.1% 14
4 PROSTATE CANC 6 11% 3.9% 48
5 GEN VISCERAL THORAC SURG CLIN 5 43% 0.7% 9
6 SERV BIOCHIM BIOL MOL SUD 5 63% 0.4% 5
7 MARTINI CLIN 4 12% 2.7% 34
8 GRP CANC GENET 4 75% 0.2% 3
9 MED UNIT MOL ONCOL TRANSFER 4 75% 0.2% 3
10 PROSTATE DIS 4 11% 2.4% 30

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000181611 DIFFERENTIAL GENE EXPRESSION DETECTION//CANCER OUTLIER PROFILE ANALYSIS//BREAST CANC DIAG TREATMENT HENAN
2 0.0000130779 PROSTATIC INTRAEPITHELIAL NEOPLASIA//ATYPICAL SMALL ACINAR PROLIFERATION//ALPHA METHYLACYL COA RACEMASE
3 0.0000109228 NKX31//LOBUND//3 2 DIMETHYL 4 AMINOBIPHENYL
4 0.0000101081 NORPEG//N COPINE//PSGR
5 0.0000100575 LZTS1//UROGENE//NUCLEAR ROUNDNESS
6 0.0000099400 ACTIVE SURVEILLANCE//WATCHFUL WAITING//PROSTATE SPECIFIC ANTIGEN
7 0.0000089921 RNASEL//HEREDITARY PROSTATE CANCER//8Q24
8 0.0000070173 SPLICED LEADER//TRANS SPLICING//CIRCULAR RNA
9 0.0000068635 PROSTATE SPECIFIC ANTIGEN//FREE PSA//FREE PROSTATE SPECIFIC ANTIGEN
10 0.0000062001 RRBS//CPG ISLANDS//METHYLTRANSFERASE ACTIVITY